ILK-IN-3( —— )

Catalog No. M22072 CAS No. 6975-75-3

ILK-IN-3 is an inhibitor of integrin linked kinase, and with antitumor activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	67	In Stock
5MG	61	In Stock
10MG	101	In Stock
25MG	202	In Stock
50MG	323	In Stock
100MG	449	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

ILK-IN-3
Note

Research use only, not for human use.
Brief Description

ILK-IN-3 is an inhibitor of integrin linked kinase, and with antitumor activity.
Description

ILK-IN-3 is an inhibitor of integrin linked kinase, and with antitumor activity.(In Vitro):ILK-IN-3 (compound 4, 10 μM) inhibits DYRK1, GSK3α/β, CDK5/p25 kinase activity to 17%, 51%, 47%, 95%, respectively.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

Integrin
Recptor

Integrin
Research Area

——
Indication

——

Chemical Information

CAS Number

6975-75-3
Formula Weight

232.24
Molecular Formula

C10H12N6O?
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 83.33 mg/mL (358.81 mM)
SMILES

COC1=CC=C(C=C1)N=NC2=C(NN=C2N)N
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Jessica Kalra, et al. Validating the Use of a Luciferase Labeled Breast Cancer Cell Line, MDA435LCC6, as a Means to Monitor Tumor Progression and to Assess the Therapeutic Activity of an Established Anticancer Drug, Docetaxel (Dt) Alone or in Combination With the ILK Inhibitor, QLT0267. Cancer Biol Ther. 2011 May 1;11(9):826-38.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks